Ciencias de la Salud
Área
Rosa
Ayesa Arriola
Publikationen, an denen er mitarbeitet Rosa Ayesa Arriola (16)
2023
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14
2022
-
Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort
Psychological Medicine, Vol. 52, Núm. 4, pp. 770-779
2019
-
Verbal memory and voxel based morphometry in first episode non-Affective psychosis: A process oriented approach
Neuropsychology, Vol. 33, Núm. 4, pp. 568-580
2016
-
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients
European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 7, pp. 619-628
-
Evidence for trait related theory of mind impairment in first episode psychosis patients and its relationship with processing speed: A 3 year follow-up study
Frontiers in Psychology, Vol. 7, Núm. MAY
2015
-
Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis
Cognitive Neuropsychiatry, Vol. 20, Núm. 2, pp. 144-156
2014
-
Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?
Schizophrenia Research, Vol. 157, Núm. 1-3, pp. 271-277
-
No sex differences in neuropsychological performance in first episode psychosis patients
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 48, pp. 149-154
2013
-
Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study
Schizophrenia Research, Vol. 150, Núm. 1, pp. 121-128
-
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone
Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625
-
Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 43, pp. 23-28
2012
-
Homocysteine and cognition in first-episode psychosis patients
European Archives of Psychiatry and Clinical Neuroscience, Vol. 262, Núm. 7, pp. 557-564
2011
-
Insight dimensions in first-episode psychosis patients: Clinical, cognitive, pre-morbid and socio-demographic correlates
Early Intervention in Psychiatry, Vol. 5, Núm. 2, pp. 140-149
2010
-
Cannabis use and cognitive functioning in first-episode schizophrenia patients
Schizophrenia Research, Vol. 124, Núm. 1-3, pp. 142-151
-
White matter integrity and cognitive impairment in first-episode psychosis
American Journal of Psychiatry, Vol. 167, Núm. 4, pp. 451-458
2009
-
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: A randomized, controlled 1-year follow-up comparison
Journal of Clinical Psychiatry, Vol. 70, Núm. 5, pp. 717-729